01099.HK
Sinopharm Group Co. Ltd.
HKSE · Healthcare · Medical - Distribution · CN
HKD 15.92
−0.25%Margins
Gross margin
7.0%
EBITDA margin
3.8%
EBIT margin
3.0%
Net margin
1.2%
FCF margin
3.3%
8.3%
Return on equity
1.7%
Return on assets
10.1%
Return on invested capital
1.43x
Asset turnover
HKD 23.7B
Cash from operations
HKD 16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026